A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : HDRS-17
Long Form : Hamilton Depression Rating Scale-17
No. Year Title Co-occurring Abbreviation
1  2023 P50 sensory gating, cognitive deficits and depressive symptoms in first-episode antipsychotics-naïve schizophrenia. FEAN, MCCB, PANSS, SCZ, SG-P50
2  2023 Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: a prospective observational study. MDD, PDQ-D, SCD
3  2022 A study protocol for an ongoing multi-arm, randomized, double-blind, sham-controlled clinical trial with digital features, using portable transcranial electrical stimulation and internet-based behavioral therapy for major depression disorders: The PSYLECT study. iBT, MDD, ptES, TES
4  2022 Effect of high frequency versus theta-burst repetitive transcranial magnetic stimulation on suicidality in patients with treatment-resistant depression. DLPFC, iTBS, rTMS, TRD
5  2021 DNA methylations of brain-derived neurotrophic factor exon VI are associated with major depressive disorder and antidepressant-induced remission in females. BDNF, CTQ, LES, MDD
6  2021 Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression. BDI-II, MADRS, MID, SF-36
7  2021 Fatigue prevalence and associated factors in patients with multiple system atrophy. ESS, FSS, HAMA, MMSE, MSA, NMSS, PSQI, RBDSQ, UMSARS
8  2021 The correlation of facial emotion recognition in patients with drug-naive depression and suicide ideation. MDD, RBANS, SI
9  2020 Aerobic exercise or stretching as add-on to inpatient treatment of depression: Similar antidepressant effects on depressive symptoms and larger effects on working memory for aerobic exercise alone. AE, BDI, BMI
10  2020 Psychometric properties of the MATRICS Consensus Cognitive Battery (MCCB) in Chinese patients with major depressive disorder. BD, MCCB, MDD, MoCA, SCH
11  2020 Psychotic depression in hospitalized patients: Longitudinal outcomes of psychotic vs. nonpsychotic depression among inpatients. BPRS, CGI, GAF
12  2019 A 6-day combined wake and light therapy trial for unipolar depression. BDI-II, VAS
13  2019 A Propensity Score Analysis of Homework Adherence-Outcome Relations in Cognitive Behavioral Therapy for Depression. CBT, QIDS-SR
14  2019 Transcranial direct current stimulation for the treatment of major depressive disorder: A meta-analysis of randomized controlled trials. CENTRAL, CI, CNKI, MADRS, MD, MDD, tDCS
15  2017 Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study. dACC, SMA, SUVs, TRD
16  2016 Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study. BD, EPO, hs-CRP, IL-18, IL-6, TRD, YMRS
17  2016 Efficacy and safety of an adjunctive mGlu2 receptor positive allosteric modulator to a SSRI/SNRI in anxious depression. MDD
18  2016 Obsessive-compulsive adults with and without childhood ADHD symptoms. ADHD, BAI, BIS-11, OCD, WURS, Y-BOCS
19  2016 Seasonal mood changes in patients with obsessive-compulsive disorder. BAI, GSS, OCD, S-SAD, SAD, SPAQ, Y-BOCS
20  2015 Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study. AA, ASEX, BARS, CGI-I, IFS, MADRS, MDD, SDS, SW
21  2015 Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response. BPRS, CGI, CGI-S, ECT, YMRS
22  2015 Smartphone data as an electronic biomarker of illness activity in bipolar disorder. YMRS
23  2015 Symptom Dimensions, Smoking and Impulsiveness in Obsessive-Compulsive Disorder. BAI, BIS.11, FTND, OCD, Y-BOCS
24  2015 The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study. BD, BDNF, EPO, TRD, YMRS
25  2014 Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial. GAD
26  2014 Electronic monitoring of psychomotor activity as a supplementary objective measure of depression severity. ---
27  2014 Leukocyte mitochondrial DNA copy number in blood is not associated with major depressive disorder in young adults. GAF, HC, HDRS, MDD, mtDNA, qPCR
28  2014 Smartphone data as objective measures of bipolar disorder symptoms. YMRS
29  2013 Childhood maltreatment and adult proinflammatory status in patients with major depression. CTQ, PBI
30  2013 Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. BDI-21, EPO, GAF, RAVLT, WHOQOL-BREF
31  2013 Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia. CDSS, MADRS, PANSS
32  2010 Brief cognitive behavioral therapy compared to general practitioners care for depression in primary care: a randomized trial. PC, PHQ-9, SCID-I
33  2010 Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. EPO, RAVLT
34  2006 Polysomnographic and symptomatological analyses of major depressive disorder patients treated with mirtazapine. MDD, REM, SWS
35  2002 An open trial of mirtazapine in menopausal women with depression unresponsive to estrogen replacement therapy. BDI, CGI, ERT, SCID-IV
36  1994 [Application of a structured interview guide adapted to 4 depression scales]. MADRS